SNU Eye Clinic doctor leads Alcon symposium on new multifocal lens

7 hours ago
SNU Eye Clinic doctor leads Alcon symposium on new multifocal lens

By AI, Created 8:56 AM UTC, May 29, 2026, /AGP/ – Dr. Chung Eui Sang of SNU Eye Clinic moderated Alcon Korea’s Clareon PanOptix Pro & UNITY Launch Symposium in Seoul on May 19, where ophthalmologists discussed clinical use of the new multifocal intraocular lens and changing patient expectations. The lens aims to improve light utilization and visual clarity as cataract and presbyopia care increasingly focuses on daily visual quality.

Why it matters: - Cataract and presbyopia patients are increasingly looking beyond basic vision correction. - Lens choice is now tied to lifestyle, work demands and visual comfort, not just surgical success. - The shift is pushing interest in multifocal intraocular lenses that can reduce reliance on glasses.

What happened: - Dr. Chung Eui Sang, chief director of SNU Eye Clinic in Korea, moderated Alcon Korea’s “Clareon PanOptix Pro & UNITY Launch Symposium” on May 19 in Seoul. - About 150 ophthalmologists attended to discuss intraocular lens technologies, surgical experience, clinical cases and patient satisfaction. - Dr. Chung, an Alcon PanOptix reference doctor, shared firsthand surgical applications and early clinical experience with Clareon PanOptix Pro.

The details: - Clareon PanOptix Pro is a premium multifocal intraocular lens developed by Alcon. - Alcon says the new lens improves light utilization and visual clarity compared with the previous Clareon PanOptix lens. - The existing lens had about 88% light utilization, while Clareon PanOptix Pro reaches up to 94%. - The higher light utilization is designed to reduce visual interruptions during focus changes and create a smoother visual experience. - The symposium also focused on future developments in multifocal IOLs. - Clinicians discussed glare reduction, night vision performance and intermediate-distance usability as real-world factors in lens selection. - Global aging and rising digital device use have increased the number of cataract patients. - Presbyopia cataract cases often combine lens opacity with reduced near vision, making lifestyle-based lens selection more important.

Between the lines: - The discussion reflects a broader move in ophthalmology toward outcome measures that matter in daily life. - Patient satisfaction is becoming a key differentiator for premium lens options. - Seoul remains an active market for advanced cataract and vision correction care, especially for international patients.

What’s next: - Dr. Chung said SNU Eye Clinic will continue sharing clinical experience and research findings to improve patient satisfaction. - SNU Eye Clinic is expanding its global patient care system as international demand for presbyopia cataract and vision correction treatment in Korea grows. - The clinic offers multilingual interpretation in English, Chinese, Mongolian and other languages. - SNU Eye Clinic provides same-day examinations, surgical consultations and post-operative follow-up in an integrated care process. - The clinic aims to further strengthen its role as a premium medical hub in Gangnam, Seoul.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Mongolia Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

Mongolia Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.